Recent advances in vaccine and immunotherapy for COVID-19

Ali A. Rabaan; Shamsah H. Al-Ahmed; Ranjit Sah; Jaffar A. Al-Tawfiq; Ayman M. Al-Qaaneh; Lamiaa H. Al-Jamea; Alexander Woodman; Manaf Al-Qahtani; Shafiul Haque; Harapan Harapan; D. Katterine Bonilla-Aldana; Pavan Kumar; Kuldeep Dhama; Alfonso J. Rodriguez-Morales

doi:10.1080/21645515.2020.1825896

Recent advances in vaccine and immunotherapy for COVID-19

Ali A. Rabaan
, Shamsah H. Al-Ahmed
, Ranjit Sah
, Jaffar A. Al-Tawfiq
, Ayman M. Al-Qaaneh
, Lamiaa H. Al-Jamea
, Alexander Woodman
, Manaf Al-Qahtani
, Shafiul Haque
, Harapan Harapan
, D. Katterine Bonilla-Aldana
, Pavan Kumar
, Kuldeep Dhama
, Alfonso J. Rodriguez-Morales

Producción científica: Artículo Científico › Artículo original › revisión exhaustiva

32 Citas (Scopus)

Resumen

The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

Idioma original	Inglés estadounidense
Páginas (desde-hasta)	3011-3022
-	12
Publicación	Human Vaccines and Immunotherapeutics
Volumen	16
N.º	12
DOI	https://doi.org/10.1080/21645515.2020.1825896
Estado	Indizado - 2020
Publicado de forma externa	Sí

Nota bibliográfica

Publisher Copyright:
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1080/21645515.2020.1825896

Citar esto

Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Al-Tawfiq, J. A., Al-Qaaneh, A. M., Al-Jamea, L. H., Woodman, A., Al-Qahtani, M., Haque, S., Harapan, H., Bonilla-Aldana, D. K., Kumar, P., Dhama, K., & Rodriguez-Morales, A. J. (2020). Recent advances in vaccine and immunotherapy for COVID-19. Human Vaccines and Immunotherapeutics, 16(12), 3011-3022. https://doi.org/10.1080/21645515.2020.1825896

@article{966694aca6f94de0a1c4a94040e4fbdf,

title = "Recent advances in vaccine and immunotherapy for COVID-19",

abstract = "The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.",

keywords = "COVID-19, SARS-CoV-2, immunotherapeutics, pandemic, vaccine",

author = "Rabaan, \{Ali A.\} and Al-Ahmed, \{Shamsah H.\} and Ranjit Sah and Al-Tawfiq, \{Jaffar A.\} and Al-Qaaneh, \{Ayman M.\} and Al-Jamea, \{Lamiaa H.\} and Alexander Woodman and Manaf Al-Qahtani and Shafiul Haque and Harapan Harapan and Bonilla-Aldana, \{D. Katterine\} and Pavan Kumar and Kuldeep Dhama and Rodriguez-Morales, \{Alfonso J.\}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s). Published with license by Taylor \& Francis Group, LLC.",

year = "2020",

doi = "10.1080/21645515.2020.1825896",

language = "American English",

volume = "16",

pages = "3011--3022",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor and Francis Ltd.",

number = "12",

}

Rabaan, AA, Al-Ahmed, SH, Sah, R, Al-Tawfiq, JA, Al-Qaaneh, AM, Al-Jamea, LH, Woodman, A, Al-Qahtani, M, Haque, S, Harapan, H, Bonilla-Aldana, DK, Kumar, P, Dhama, K & Rodriguez-Morales, AJ 2020, 'Recent advances in vaccine and immunotherapy for COVID-19', Human Vaccines and Immunotherapeutics, vol. 16, n.º 12, pp. 3011-3022. https://doi.org/10.1080/21645515.2020.1825896

TY - JOUR

T1 - Recent advances in vaccine and immunotherapy for COVID-19

AU - Rabaan, Ali A.

AU - Al-Ahmed, Shamsah H.

AU - Sah, Ranjit

AU - Al-Tawfiq, Jaffar A.

AU - Al-Qaaneh, Ayman M.

AU - Al-Jamea, Lamiaa H.

AU - Woodman, Alexander

AU - Al-Qahtani, Manaf

AU - Haque, Shafiul

AU - Harapan, Harapan

AU - Bonilla-Aldana, D. Katterine

AU - Kumar, Pavan

AU - Dhama, Kuldeep

AU - Rodriguez-Morales, Alfonso J.

PY - 2020

Y1 - 2020

N2 - The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

AB - The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

KW - COVID-19

KW - SARS-CoV-2

KW - immunotherapeutics

KW - pandemic

KW - vaccine

UR - https://www.scopus.com/pages/publications/85095809734

U2 - 10.1080/21645515.2020.1825896

DO - 10.1080/21645515.2020.1825896

M3 - Original Article

C2 - 33156739

AN - SCOPUS:85095809734

SN - 2164-5515

VL - 16

SP - 3011

EP - 3022

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 12

ER -

Recent advances in vaccine and immunotherapy for COVID-19

Resumen

Nota bibliográfica

ODS de las Naciones Unidas

Acceder al documento

Huella

Citar esto